iPLATO Healthcare, a UK leader in mHealth, revealed that the number of patients connected to its platform surpassed five million in late 2012. Working in partnership with healthcare commissioners, commissioning support teams and practices iPLATO added over 5,000 patients per day to the platform in 2012. The company attributes the accelerated uptake to growing patient and practitioner acceptance for mobile services as well as maturing business cases for increased provider productivity, improved public health promotion and transformed support to people with long term conditions. iPLATO expects its British network to reach 10 million patients within 2 years. The company is looking for partners to establish networks in other countries.
Tobias Alpsten, CEO of iPLATO, said: "Continued support from healthcare commissioners across the NHS has been an instrumental in enabling us to reach our first five million patients. However, this is only a step on the way. There are more than 6 billion mobile handsets in the world today, each owned by a person for whom health is important, so there is a lot of room for growth. In addition to our in-house research and development efforts we actively seek partners with specific clinical skills to add to our overall service offering. We owe our healthcare provider partners and patients best-of-breed services. We expect many of these new, exiting, services to be delivered in partnership with universities, hospitals, clinical experts and other innovation companies across the world. We are especially interested in services that support people with long term conditions such as hypertension, diabetes, asthma, depression and coronary heart disease."
Related news articles:
- iPLATO's Profile
About iPLATO
iPLATO Healthcare is British innovation company dedicated to mobile health since 2006.
iPLATO's evidence based mobile health solutions have proven to improve patient access to healthcare, to enable powerful health promotion targeted at people at risk and to support people with long term conditions.
Serving millions of patients and thousands of healthcare professionals every day iPLATO has emerged as the leader in mobile health. Across this network the company is running campaigns to promote smoking cessation, weight loss, childhood immunisation and cancer screening as well as mobile disease management services for people with epilepsy, COPD and HIV.
iPLATO Healthcare's mission is to, in partnership with healthcare professionals and provider organisations, support patients in achieving longer, healthier lives.